Table 3. Opioid Consumption and Frequency of Complications in Study Groups ^a.

	Study Groups		P Value
	Placebo (n = 30)	Gabapentin (n = 30)
Patients Requiring Opioid	14 (46.7)	7 (23.3)	0.058
Dose of Consumed Opioid, mg	32.5 ± 14.1	20.7 ± 13.7	0.08
Nausea/Vomiting	10 (33.3)	3 (10)	0.028
Agitation	11 (36.7)	4 (13.3)	0.037
Headache	3 (10)	1 (3.3)	0.3

^aData presented as Mean ± SD or No. (%).